ATE30585T1 - Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen. - Google Patents

Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.

Info

Publication number
ATE30585T1
ATE30585T1 AT84306332T AT84306332T ATE30585T1 AT E30585 T1 ATE30585 T1 AT E30585T1 AT 84306332 T AT84306332 T AT 84306332T AT 84306332 T AT84306332 T AT 84306332T AT E30585 T1 ATE30585 T1 AT E30585T1
Authority
AT
Austria
Prior art keywords
treatment
diabetic complications
spirosuccinimide
application
disclosed
Prior art date
Application number
AT84306332T
Other languages
English (en)
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE30585T1 publication Critical patent/ATE30585T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
AT84306332T 1983-09-23 1984-09-17 Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen. ATE30585T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53544483A 1983-09-23 1983-09-23
EP84306332A EP0136143B1 (de) 1983-09-23 1984-09-17 Spirosuccinimide und ihre Anwendung in der Behandlung von Zuckerkrankheitskomplikationen

Publications (1)

Publication Number Publication Date
ATE30585T1 true ATE30585T1 (de) 1987-11-15

Family

ID=24134256

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84306332T ATE30585T1 (de) 1983-09-23 1984-09-17 Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.

Country Status (6)

Country Link
EP (1) EP0136143B1 (de)
JP (1) JPS6092264A (de)
AT (1) ATE30585T1 (de)
DE (1) DE3467166D1 (de)
DK (1) DK451184A (de)
GR (1) GR80428B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3670570D1 (de) * 1986-09-02 1990-05-31 Alcon Lab Inc Aldose-reductase-hemmer, nuetzlich bei der behandlung von glaukom.
US4900739A (en) * 1988-10-20 1990-02-13 American Home Products Corp. Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US4946858A (en) * 1988-10-20 1990-08-07 American Home Products Corporation Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
DE3262294D1 (en) * 1981-05-13 1985-03-28 Ici Plc Pharmaceutical compositions containing spiro succinimide derivatives

Also Published As

Publication number Publication date
EP0136143A3 (en) 1985-05-15
DK451184A (da) 1985-03-24
EP0136143A2 (de) 1985-04-03
DK451184D0 (da) 1984-09-21
EP0136143B1 (de) 1987-11-04
DE3467166D1 (en) 1987-12-10
GR80428B (en) 1985-01-22
JPS6092264A (ja) 1985-05-23

Similar Documents

Publication Publication Date Title
SE7906949L (sv) Nya spiro-oxazolidindioner
DK15589A (da) Kemiske forbindelser
ATE399547T1 (de) Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia
DE3785602T2 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE30585T1 (de) Spirosuccinimide und ihre anwendung in der behandlung von zuckerkrankheitskomplikationen.
DE69431199T2 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
DE69325141D1 (de) Behandlung von lignozellulosehaltigen Materialien
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
IE832854L (en) Spiro-3-hetero-azolones for treatment of diabetic¹complications.
DK316788D0 (da) Farmaceutisk praeparat og dets anvendelse
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
DE3162277D1 (en) N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound
FI861125A0 (fi) Vid vaord av diabeteskomplikationer tillaempade spiroimidazoler.
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee